Skip to content

Comparison of Three Methods of Hemoglobin Monitoring

Comparison of Three Methods of Hemoglobin Monitoring in Patients Undergoing Spine or Hip Surgery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01284296
Enrollment
20
Registered
2011-01-26
Start date
2010-08-31
Completion date
2011-10-31
Last updated
2012-05-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Digital Block

Brief summary

This study will further investigate the Masimo SpHb \[FDA Approved\] continuous non-invasive hemoglobin monitor in spine surgery patients. (See NCT00792597) We will investigate the effect of enhanced circulation to the finger (which will be attached to the sensor) following a local injection (digital block) of lidocaine (an FDA approved local anesthetic), and assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb).

Detailed description

We have completed a study with 20 patients using the latest version of the SpHb monitor software and finger sensor. The purpose of this study is to assess the accuracy of the SpHb reading as it relates to a standard laboratory hemoglobin value (tHb) following the digital block.

Interventions

DRUGLidocaine digital block

One dose of lidocaine 2% injected locally into one finger (2 mls total)

DEVICEMasimo SpHb continuous hemoglobin monitor

Masimo SpHb continuous hemoglobin monitor

Sponsors

University of California, San Francisco
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Male or non-pregnant female 18 y/o or older * ASA Classification 1, 2 or 3 * Scheduled to undergo spine or hip revision surgery

Exclusion criteria

* Pregnant or nursing * Patients who in the study investigators clinical judgement would not be suitable for research.

Design outcomes

Primary

MeasureTime frame
Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.A minimum of 2-4 differences recorded approximately hourly during surgery

Countries

United States

Participant flow

Participants by arm

ArmCount
Digital Block
The difference between intermittent readings of the SpHb continuous hemoglobin monitor with the digital lidocaine block and a laboratory hemoglobin were evaluated for patients undergoing spine surgery and blood loss.
20
Total20

Baseline characteristics

CharacteristicDigital Block
Age, Categorical
<=18 years
0 Participants
Age, Categorical
>=65 years
8 Participants
Age, Categorical
Between 18 and 65 years
12 Participants
Sex: Female, Male
Female
12 Participants
Sex: Female, Male
Male
8 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 20
serious
Total, serious adverse events
0 / 20

Outcome results

Primary

Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.

Time frame: A minimum of 2-4 differences recorded approximately hourly during surgery

ArmMeasureGroupValue (NUMBER)
Digital Block (All Perfusion Indices 0.29-8.3)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.0.5-1.0 g/dL19 percentage of hemoglobin readings
Digital Block (All Perfusion Indices 0.29-8.3)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.1.6-2.0 g/dL17 percentage of hemoglobin readings
Digital Block (All Perfusion Indices 0.29-8.3)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.1.1-1.5 g/dL18 percentage of hemoglobin readings
Digital Block (All Perfusion Indices 0.29-8.3)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.>2.0 g/dL9 percentage of hemoglobin readings
Digital Block (All Perfusion Indices 0.29-8.3)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.< 0.5 g/dL37 percentage of hemoglobin readings
Digital Block (Perfusion Indices >2.0)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.>2.0 g/dL3 percentage of hemoglobin readings
Digital Block (Perfusion Indices >2.0)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.< 0.5 g/dL37 percentage of hemoglobin readings
Digital Block (Perfusion Indices >2.0)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.0.5-1.0 g/dL26 percentage of hemoglobin readings
Digital Block (Perfusion Indices >2.0)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.1.1-1.5 g/dL20 percentage of hemoglobin readings
Digital Block (Perfusion Indices >2.0)Categorical Groups Based on Magnitude of Differences Between Noninvasive (SpHb) and Laboratory Co-Oximeter (tHb) Hemoglobin in Patients With a Finger Regional Anesthetic Block.1.6-2.0 g/dL14 percentage of hemoglobin readings

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026